[Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].

doi:10.1016/j.patol.2017.11.002

Article

[Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].

Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia - 1 Jan 2000

Oaknin Ana, Guarch Rosa, Barretina Pilar, Hardisson David, González-Martín Antonio, Matías-Guiu Xavier, Pérez-Fidalgo Alejandro, Vieites Begoña, Romero Ignacio, Palacios José

Abstract excerpt

Advances in the understanding of the histological and molecular characteristics of ovarian cancer now allow 5subtypes to be identified, leading to a more refined therapeutic approach and improved clinical trials. Each of the subtypes has specific histological features and a particular biomarker expression, as well as mutations in different genes, some of which have prognostic and predictive value. CA125 and HE4...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

[Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].

Abstract excerpt

Topics

Related research